IL6 and COVID-19: Similar results were found in two other clinical studies: the levels of IL-2R, IL-6, and TNF-α were significantly higher in patients with severe COVID-19 than in those with moderate disease, suggesting that the cytokine storm is a key factor in the deterioration of patients with COVID-19 (33, 34).